ASCA IgG

The ASCA IgG analysis is a specialized laboratory test available at IntroLab in Belgrade. This test detects IgG (immunoglobulin G) type antibodies to Saccharomyces cerevisiae (ASCA) in the blood. The presence of ASCA IgG can be linked to certain bowel diseases, including Crohn’s disease and ulcerative colitis.

What is ASCA IgG?

IgG represents a specific class of antibodies. These antibodies are specifically directed against proteins found in Saccharomyces cerevisiae, a type of yeast commonly used in the baking and brewing industries. Identifying these antibodies in the blood can indicate the presence of specific health conditions, especially inflammatory bowel diseases like Crohn’s disease.

When is the analysis performed?

Testing is recommended for individuals who exhibit symptoms that may indicate inflammatory bowel diseases. This can include symptoms such as:

• Prolonged diarrhea
• Unexplained weight loss
• Abdominal pain
• Fatigue
• Impaired nutrient absorption

Additionally, the ASCA IgG analysis is intended for individuals suspected of having certain inflammatory bowel diseases, such as Crohn’s disease. This test helps distinguish Crohn’s disease from ulcerative colitis and other types of gastrointestinal disorders. It is particularly useful for patients who exhibit symptoms suggestive of these diseases, such as chronic diarrhea, abdominal pain, and unexplained weight loss. The presence of ASCA IgG antibodies can indicate an immune response to Saccharomyces cerevisiae, which is often associated with Crohn’s disease.

About Crohn’s Disease

Crohn’s disease is a chronic inflammatory bowel disease that can affect any part of the gastrointestinal tract, from the mouth to the anus, but most commonly affects the last part of the small intestine (ileum) and the colon. It is characterized by inflammation that can deeply penetrate the walls of the intestines. Symptoms of Crohn’s disease include abdominal pain, diarrhea, fatigue, weight loss, and occasional rectal bleeding. The disease can be unpredictable, with periods of exacerbation and remission.

Diagnosis of Crohn’s disease involves a series of laboratory tests and analyses. The most common are:

• Complete Blood Count (CBC) – reveals signs of anemia or infection.
• Biochemical analyses – can indicate nutritional deficits.
• C-reactive protein (CRP) and erythrocyte sedimentation rate (ESR) – markers that indicate the presence of inflammation in the body.
• Fecal calprotectin – a test that helps detect inflammation in the intestines; high values can indicate active Crohn’s disease.

In addition to laboratory tests, diagnostics may include endoscopic examinations such as colonoscopy, taking biopsies for histopathological analysis, and various imaging methods such as MR enterography for a more detailed view of the intestines. Timely diagnosis and appropriate treatment are key to managing symptoms and preventing complications of the disease.

Interpretation of results

The interpretation of test results is done in the context of the patient’s symptoms, medical history, and other laboratory findings. Elevated IgG antibody levels can indicate the presence of inflammatory bowel disease, especially Crohn’s disease. However, it is important to note that low levels do not necessarily exclude the possibility of the disease.

Testing Procedure

Testing is performed based on a sample of the patient’s blood. Blood is usually taken from a vein in the arm. The procedure is quick, safe, and relatively painless. No specific preparation is needed before this test.

Specifics of the ASCA IgG Analysis

ASCA IgG represents just one part of the spectrum of ASCA antibodies. There is also an ASCA IgA test that detects another subclass of these antibodies. Both types of antibodies are important in the context of inflammatory bowel diseases but can also occur in other autoimmune conditions. Combined analysis of both types of antibodies can provide a broader picture of the patient’s immune response, which can be useful in the diagnostic process.

Although ASCA IgG and ASCA IgA antibodies are directed at the same antigen, they differ in their type and role in the immune response:

ASCA IgG:

• IgG (immunoglobulin G) antibodies are the most common type of antibodies in the bloodstream and are crucial for long-term immunity.
• ASCA IgG antibodies are associated with the body’s general reaction to infections or inflammatory processes.
• In diagnosing Crohn’s disease, the presence of ASCA IgG antibodies is often used to confirm the diagnosis, especially when combined with other biomarkers.

ASCA IgA:

• IgA (immunoglobulin A) antibodies are primarily present in mucosa and secretions (such as saliva and tears) and protect the body’s entrances from pathogens.
• ASCA IgA antibodies are specifically important for identifying localized immune reactions in the gastrointestinal tract.
• High levels of ASCA IgA can indicate localized immune activity in the intestines, which is relevant for diagnosing inflammatory bowel diseases such as Crohn’s disease.

The difference in types of ASCA antibodies can help understand the nature of the immune response in the body and provide more precise information about the patient’s condition, which is essential for directing therapeutic approaches.